A. Kavlie

发表

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines

Pojen P. Chen, H. Liao, J. Kappes, 2010, The Journal of experimental medicine.

A Novel Angiopoietin-2 Selective Fully Human Antibody with Potent Anti-Tumoral and Anti-Angiogenic Efficacy and Superior Side Effect Profile Compared to Pan-Angiopoietin-1/-2 Inhibitors

Y. Kienast, C. Klein, Markus Thomas, 2013, PloS one.

Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation.

M. Amarzguioui, H. Prydz, K. Sletten, 1998, Biochemical and biophysical research communications.

Homozygous Q100R mutations in the second EGF-like domain of factor VII.

H. Prydz, A. Kavlie, 1999, Blood.

r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction

Laura A. Sullivan, C. Roland, J. Richardson, 2010, PloS one.

A novel gene mutation in the 60s loop of human coagulation factor VII – inhibition of interdomain crosstalk

H. Prydz, M. Wiiger, H. Stormorken, 2003, Thrombosis and Haemostasis.

Characterization of a Factor VII Molecule Carrying a Mutation in the Second Epidermal Growth Factor-like Domain

H. Prydz, H. Stormorken, A. Kavlie, 1998, Thrombosis and Haemostasis.

Monoclonal antibodies reactive with serum IgM and leukocytes from Atlantic salmon (Salmo salarL.)

H. Wergeland, C. Endresen, A. Kavlie, 1995 .

Two novel mutations in the human coagulation factor VII promoter

H. Prydz, V. Rasi, A. Kavlie, 2003, Thrombosis and Haemostasis.

The influence of the -401G/T and -402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII.

H. Arnesen, J. I. Pedersen, M. Veierød, 2005, Thrombosis research.

Construction, evaluation and refinement of a large human antibody phage library based on the IgD and IgM variable gene repertoire.

J. E. Stacy, G. Løset, O. Brekke, 2005, Journal of immunological methods.